Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxalidine versus sufentanil for postoperative analgesia and postoperative cognitive dysfunction in older adults undergoing lower limb long bone surgery
ChiCTR2400090887Phase 4Not yet recruiting
- Sponsor
- Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oliceridine and sufentanil in postoperative pain and post-operative cognitive decline (POCD) (2 arms), sponsored by Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University. Primary endpoint: Incidence of postoperative cognitive impairment. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
oliceridinesufentanil
03
Conditions
postoperative painpost-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2400090887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090887.